Greenwood Luba
SEC insider (Form 3/4/5 filer). CIK 0001853815. Director at IN8BIO, INC. (INAB) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on May 9, 2026. Located in NEW YORK, NY.
Companies Greenwood Luba has filed insider reports for
- IN8BIO, INC. (INAB): Director
- Traws Pharma, Inc. (TRAW): Director
Greenwood Luba
CIK: 0001853815
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 9, 2026INAB
IN8BIO, INC.
AwardDirectStock Option (right to buy)
22K shares- - May 8, 2025INAB
IN8BIO, INC.
AwardDirectStock Option (right to buy)
63.2K shares- - Dec 19, 2024INAB
IN8BIO, INC.
AwardDirectStock Option (right to buy)
39.4K shares- - Sep 16, 2024TRAW
Traws Pharma, Inc.
AwardDirectStock Option (Right to Purchase)
164K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 9, 2026 |  INAB IN8BIO, INC. | Award Stock Option (right to buy) | 22,000 | - | - | Direct |
| May 8, 2025 | INAB IN8BIO, INC. | Award Stock Option (right to buy) | 63,150 | - | - | Direct |
| Dec 19, 2024 | INAB IN8BIO, INC. | Award Stock Option (right to buy) | 39,449 | - | - | Direct |
| Sep 16, 2024 |  TRAW Traws Pharma, Inc. | Award Stock Option (Right to Purchase) | 164,000 | - | - | Direct |
1-4 of 4 transactions